Primary |
Osteoporosis |
80.0% |
Bone Disorder |
20.0% |
|
Medication Error |
20.0% |
Product Label Issue |
20.0% |
Product Quality Issue |
20.0% |
Volvulus |
20.0% |
Vomiting |
20.0% |
|
Secondary |
Product Used For Unknown Indication |
20.0% |
Hypocalcaemia |
11.4% |
Anaemia |
8.6% |
Gastrooesophageal Reflux Disease |
8.6% |
Pain In Extremity |
8.6% |
Uterine Leiomyoma |
8.6% |
Vitamin Supplementation |
8.6% |
Osteoporosis |
5.7% |
Urinary Tract Infection |
5.7% |
Headache |
2.9% |
Hypersensitivity |
2.9% |
Hypertension |
2.9% |
Rheumatoid Arthritis |
2.9% |
Upper-airway Cough Syndrome |
2.9% |
|
Wound Dehiscence |
20.0% |
Blood Calcium Increased |
13.3% |
Back Pain |
6.7% |
Calciphylaxis |
6.7% |
Drug Interaction |
6.7% |
Dyspnoea Exertional |
6.7% |
Nausea |
6.7% |
Respiratory Failure |
6.7% |
Total Lung Capacity Decreased |
6.7% |
Urine Analysis Abnormal |
6.7% |
Uveitis |
6.7% |
Walking Aid User |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
32.1% |
Drug Use For Unknown Indication |
20.6% |
Osteoporosis |
9.3% |
Rheumatoid Arthritis |
4.7% |
Hypertension |
4.2% |
Pain |
3.6% |
Crohn's Disease |
2.9% |
Osteopenia |
2.5% |
Supplementation Therapy |
2.2% |
Gastrooesophageal Reflux Disease |
2.1% |
Depression |
2.0% |
Vitamin Supplementation |
1.9% |
Prophylaxis |
1.9% |
Asthma |
1.6% |
Atrial Fibrillation |
1.5% |
Blood Cholesterol Increased |
1.5% |
Systemic Lupus Erythematosus |
1.5% |
Multiple Myeloma |
1.4% |
Nausea |
1.3% |
Bipolar Disorder |
1.2% |
|
Vomiting |
8.5% |
Wound Infection Staphylococcal |
7.8% |
Pain In Extremity |
7.5% |
Urinary Tract Infection |
6.8% |
Weight Decreased |
6.8% |
Pyrexia |
6.2% |
Sepsis |
5.9% |
Weight Increased |
5.9% |
Nausea |
4.9% |
Thrombocytopenia |
4.6% |
Death |
3.9% |
Injection Site Pain |
3.9% |
Paraesthesia |
3.9% |
Diarrhoea |
3.6% |
Drug Ineffective |
3.6% |
Stress Fracture |
3.6% |
Flushing |
3.3% |
Oedema Peripheral |
3.3% |
Tremor |
3.3% |
Pruritus |
2.9% |
|